The SLC6A3 gene gives your brain instructions for a transporter that clears away dopamine, a signaling chemical involved in movement, attention, motivation, and reward. This gene helps your body keep dopamine levels more balanced after nerve cells send a message. If the gene does not work well, dopamine handling can be disrupted, which may contribute to movement problems; rare severe variants can cause dopamine transporter deficiency syndrome, a condition that often begins in infancy or childhood. Common variants may also slightly influence traits such as attention, but they do not determine them.
What is a gene?
A gene is a section of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes provide the instructions for producing proteins, which are the functional parts of cells. Others mostly help govern when certain processes happen, where they take place, and how active they are. As a group, genes affect how the body develops and works, and they can influence your response to food, stress, or medications. For a deeper look at this topic, you can learn more in LearnHub.
Overview
SLC6A3Gene function
What if the gene works
Your nerve cells use the SLC6A3 gene to make the dopamine transporter, which moves dopamine back into cells after signaling. This helps keep dopamine levels balanced and supports movement, attention, and motivation.
Risk
What if the gene does not work
Severe variants in the SLC6A3 gene can cause dopamine transporter deficiency syndrome, with early movement problems and developmental delay. Milder variants may leave some transporter activity, which can delay symptom onset or reduce severity.
Treatment
What does that mean for your treatment
At present, no treatment or drug choice approach specifically guided by pathogenic or loss-of-function variants in the SLC6A3 gene is established in clinical guidelines. The SLC6A3 gene is being studied as a treatment target, including early work on gene replacement and small molecules that may improve dopamine transporter function.
Conditions associated with SLC6A3
Gene function
What if the gene works
In day-to-day life, this gene helps your brain handle dopamine, a chemical messenger linked to movement, attention, motivation, and reward. The SLC6A3 gene gives cells instructions for the main transporter that takes dopamine back up after it sends a message. Understanding how the SLC6A3 gene works can make it easier to see how the brain recycles dopamine and keeps signaling balanced.
Its protein sits on the surface of certain nerve cells and pulls dopamine back in after it is released. This is the main way your brain clears dopamine from the space between cells.
By removing dopamine after a message is sent, this transporter helps keep nerve signaling controlled and well timed. That supports smooth communication in brain pathways used for movement, focus, motivation, and reward.
Once dopamine is taken back into the cell, it can be stored and used again for future messages. This recycling helps nerve cells use dopamine efficiently during everyday brain activity.
What is a variant?
A genetic variant is a minor difference in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC6A3 gene can change the shape, stability, or cell surface delivery of the dopamine transporter, lowering how well it takes dopamine (a brain signaling chemical) back into nerve cells. Some variants leave partial activity, while more disruptive variants can leave very little or none. This range helps explain how SLC6A3 variants affect dopamine transporter function. In dopamine transporter deficiency syndrome, lower remaining activity often tracks with earlier onset and more severe movement symptoms.
How variants are linked to conditions
Pathogenic variants in the SLC6A3 gene cause dopamine transporter deficiency syndrome, a rare inherited movement condition that often begins in infancy or early childhood. Children may develop low muscle tone, delayed motor milestones, stiffness, tremor, or parkinsonism-dystonia. Research has also explored common SLC6A3 gene variants in conditions such as ADHD, but those links are not as firmly established as the SLC6A3 gene association with dopamine transporter deficiency syndrome.
A variant is not necessarily a diagnosis
Genetic variants are common in the general population and are a normal part of human biology. Most have no direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, particularly when several genes and environmental factors are involved. In some cases, however, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broad, well-confirmed evidence that specific lifestyle or environmental factors change health risk related to the SLC6A3 gene. For rare conditions linked to SLC6A3, risk is mainly shaped by the genetic changes themselves and whether they run in a family, rather than by day-to-day habits. Anyone worried about personal or family risk should speak with a doctor or genetic counselor.
Inheritance of SLC6A3 variants
SLC6A3-related conditions are inherited in an autosomal recessive pattern. This means a child must inherit one disease-causing variant in the SLC6A3 gene from each parent to be affected. Parents who each carry one variant are usually unaffected carriers, and with each pregnancy there is a 25% chance the child will inherit both variants, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither variant. In practical terms, SLC6A3 inheritance usually appears when both sides of a family pass on a variant in the same gene.
What does my SLC6A3 result mean for my family?
For families with a disease-causing SLC6A3 result linked to dopamine transporter deficiency syndrome, close relatives may also be carriers or, less often, also have the condition. Brothers and sisters of an affected child can sometimes be affected or carry the same gene change even if they seem well. Parents are often healthy carriers, and other relatives may want to learn whether carrier testing is relevant for them.
Genetic information
Genetic testing
How you find out about variants
SLC6A3 genetic testing usually uses a blood or saliva sample to read the SLC6A3 gene and look for variants. Results may show a pathogenic variant, a benign variant, or a variant of uncertain significance, and in the right clinical setting they can help confirm a diagnosis or clarify whether a variant runs in a family.
When should I consider getting a genetic test?
Consider genetic testing for the SLC6A3 gene if a baby or child has unexplained movement problems such as stiffness, unusual twisting, slow movement, or trouble with feeding and breathing, especially when symptoms start early. Testing can also help families when a close relative has this rare inherited condition.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but the amount they reveal depends on the condition and on the kind of variant involved. How the body works over time is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, it can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can influence how your body responds to medicines, so the same treatment may work well for one person but feel weaker or cause more side effects in another. Part of the reason is that inherited differences can change how the body absorbs, breaks down, moves, or responds to a drug. These differences are common and can affect both how well a medicine works and how sensitive a person is to it.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes affect a person’s response to medications. It explores connections between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body processes it. This information can support more informed and individualized treatment decisions. More on this topic is available in the LearnHub.
Drugs influenced by the SLC6A3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so questions about side effects, benefit, or medication changes are best discussed with your doctor. SLC6A3 has been studied in research on response to some ADHD medicines, but the findings are not strong enough to guide routine treatment decisions.
History
Interest in the SLC6A3 gene grew as scientists worked to identify the brain’s main dopamine transporter in the late 1980s and early 1990s. In 1991, researchers cloned this gene, giving medicine a clearer way to study dopamine signaling and the effects of stimulant drugs. From these first observations, research expanded steadily. The SLC6A3 gene then became a frequent focus in studies of attention, movement, addiction, and other brain related traits, especially through a commonly studied repeat pattern once called DAT1. Over time, its history has been shaped less by public headlines and more by its steady role in neuroscience and psychiatric genetics research.